CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Pulike Biological Engineering Inc Company Snapshot
Pulike Biological Engineering Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pulike Biological Engineering Inc with three other companies in this sector in China: Shenzhen Weiguang Biological Products Co Ltd (2017 sales of 623.39 million Chinese Renmimbi [US$91.03 million] of which 99% was Blood Products), Zhejiang Wolwo Bio Pharmaceutical Co Ltd (385.58 million Chinese Renmimbi [US$56.31 million] of which 99% was Pharmaceutical Manufacturing), and Walvax Biotechnology Company Limited (667.51 million Chinese Renmimbi [US$97.48 million] of which 81% was Production Segment).

Sales Analysis. Pulike Biological Engineering Inc reported sales of 529.90 million Chinese Renmimbi (US$77.38 million) for the year ending December of 2017. This represents a decrease of 9.1% versus 2016, when the company's sales were 583.09 million Chinese Renmimbi. Contributing to the drop in overall sales was the 47.5% decline in Technology License and Transfer Income, from 40.88 million Chinese Renmimbi to 21.45 million Chinese Renmimbi. There were also decreases in sales in Veterinary Chemicals (down 6.8% to 503.90 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Pulike Biological Engineering Inc
  Stock Performance Chart for Pulike Biological Engineering Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (9/21/2018): 13.60
(Figures in Chinese Renmimbi)
1 Week -4.9%   13 Weeks -11.1%  
4 Weeks -21.7%   52 Weeks -39.4%  
 
Pulike Biological Engineering Inc Key Data:
  Ticker: 603566 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 529,895,208
(Year Ending Jan 2018).
Employees: 1,267
  Currency: Chinese Renmimbi Market Cap: 4,402,864,000
  Fiscal Yr Ends: December Shares Outstanding: 323,740,000
  Share Type: GU Closely Held Shares: 216,197,472
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.